Healthcare
Skylight Health Group Inc.(SLHPF)
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 20, 2025 โ Jun 11, 2026
- Market Cap
- โ
- Revenue Growth
- +106.7%
- EPS Growth
- +14.0%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 20, 2025 โ Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Skylight Health Group Inc. (SLHPF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 20, 2025 โ Jun 11, 2026). Baseline metrics include revenue growth of +106.7%, EPS growth of +14.0%, a dividend yield of 0.0%. What stands out right now is revenue +106.7%, EPS +14.0%, free cash flow -354.1% with operating margin -75.3% and ROIC -25.9%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SLHPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+106.7% vs +7.6% peer median
Operating Margin
Below sector median
-75.3% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 29, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +106.7% and EPS at +14.0%, with operating margin around -75.3%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 18, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 29, 2026 | โ | +0.0% | +0.0% | โ |
2026 May 19, 2026 | โ | +0.0% | +0.0% | โ |
2026 Feb 25, 2026 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SLHPF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SLHPF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SLHPF and SPY.
Company Overview
Skylight Health Group Inc.
Other OTC
Skylight Health Group Inc. operates as a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. It operates the US multi-state primary care health network, which provides a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The company also owns and operates a proprietary electronic health record system that supports the delivery of care to patients through telemedicine and other remote monitoring system integrations. In addition, it offers a disruptive subscription-based telemedicine service for the un/under-insured population. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.
- Leadership
- Pradyum Sekar
- IPO Date
- Dec 2, 2021
- Employees
- 259
- Street Address
- 82 Hartwell Street
- Mailing
- Mississauga, ON, 02721
- Region
- Mississauga, ON, CA
- Reporting Currency
- USD
- Investor Line
- +1 855 874 4999
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.0
- Price/Book
- 0.0
Growth
- Revenue
- +106.7%
- EPS
- +14.0%
- Free Cash Flow
- -354.1%
Profitability
- Gross Margin
- 55.6%
- Operating Margin
- -75.3%
- Net Margin
- -57.7%
- ROE
- -47.8%
- ROIC
- -25.9%
Balance Sheet
- Debt/Equity
- 0.43
- Current Ratio
- 1.87
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.